Trial Profile
Umirolimus- versus a sirolimus-eluting stent in patients with coronary artery disease: optical coherence tomographic assessment of lesions
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2014
Price :
$35
*
At a glance
- Drugs Umirolimus (Primary) ; Sirolimus
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms SEVEN OCT
- 04 Feb 2014 New trial record